Premium
A review of the efficacy and tolerability of antipsychotic long‐acting injections
Author(s) -
Whyte Allison,
Parker Caroline
Publication year - 2016
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.436
Subject(s) - tolerability , antipsychotic , medicine , antipsychotic drug , atypical antipsychotic , drug , pharmacology , psychiatry , schizophrenia (object oriented programming) , adverse effect
The formulation of long‐acting injections (LAIs) as a method of delivering antipsychotics can be used to improve adherence, particularly in those unintentionally non‐adherent. Here, the authors review the efficacy and tolerability of first‐generation antipsychotic (FGA) and second‐generation antipsychotic (SGA) LAIs, analyse drug cost, give guidance on initiation regimens for SGA LAIs and discuss the future for these drugs.